Katie Piper has shared her decision to try out an “artificial eye”, 16 years after an acid attack that left her partially blind. The 41-year-old activist and Loose Women host has undergone ...

Piper Sandler raised the firm’s price target on Arhaus (ARHS) to $15 from $14 and keeps an Overweight rating on the shares after announcing the departure of CFO Dawn Phillipson and raising full ...

TV presenter Katie Piper has revealed she is trying out an “artificial eye” more than 16 years on from an acid attack that left her with life-changing burns and partial blindness. The Loose Women ...

Katie Piper, the Loose Women panellist, has revealed that she has had a prosthetic eye fitted after years of surgeries to save her real one. The decision comes after she suffered eyesight loss in ...

TV presenter Katie Piper has revealed she is trying out an “artificial eye” more than 16 years on from an acid attack that left her with life-changing burns and partial blindness. The Loose ...

Valero Energy (NYSE:VLO) +1.4% and Par Pacific (PARR) +3% in Friday's trading as Piper Sandler upgrades both stocks to Overweight from Neutral with respective $149 and $25 price targets ...

Fintel reports that on January 10, 2025, Piper Sandler upgraded their outlook for NIKE (NYSE:NKE) from Neutral to Overweight. Analyst Price Forecast Suggests 25.85% Upside As of December 23 ...

Investing.com -- Piper Sandler upgraded Nike (NYSE:NKE) to Overweight from Neutral, setting a price target of $90, up from $72 a share in a note Friday. The decision reflects confidence in CEO Elliott ...

Fintel reports that on January 10, 2025, Piper Sandler upgraded their outlook for NIKE (SNSE:NKECL) from Neutral to Overweight. There are 3,293 funds or institutions reporting positions in NIKE.

On Friday, Piper Sandler provided insights into the semiconductor sector, drawing on recent meetings with management teams at the Consumer Electronics Show (CES) in Las Vegas. The firm highlighted ...

Piper Sandler analyst Peter Keith maintained a Buy rating on Boot Barn (BOOT – Research Report) today and set a price target of $179.00. The company’s shares closed last Wednesday at $160.34.